Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-023491

Chief Financial Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tamayo Louis Edward · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-29 Grant or award : show line 1 in the form +45,000 45,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-29 Grant or award : show line 2 in the form Stock Option (right to buy) +280,000 280,000 D
Loading xslF345X05/form4-09032025_020901.xml…